Nektar Therapeutics (NKTR) Payables (2010 - 2026)
Nektar Therapeutics' Payables was $24.89 million in Q2 2026, up 74.3% from $14.28 million a year earlier and up 148.3% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Payables at Nektar Therapeutics came in at $10.77 million, down 6.8% from FY2024.
- Payables shows a five-year compound annual growth rate of -13.4% (FY2020 to FY2025).
- In earlier years, Payables was $11.56 million in FY2024 (+17.4%), $9.85 million in FY2023 (-24.1%), $12.98 million in FY2022 (+33.2%) and $9.75 million in FY2021 (-56.0%).
- The Q2 2026 figure marks the highest quarterly Payables in data going back to Q4 2010.
- Compared with a year earlier, Payables was higher in six of the last eight quarters, with growth averaging 63.4%.
- The best year-over-year quarter for Payables over five years was Q3 2024 (growth of 160.9%); the worst was Q2 2023 (a decline of 78.8%).
- Per Business Quant data, NKTR's Payables in the three quarters before Q2 2026 was $10.03 million (Q1 2026), $10.77 million (Q4 2025) and $15.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Nektar Therapeutics | 2.00 Bn | 227.61 Mn | - | 24.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.89 Mn |
| Mar 31, 2026 | 10.03 Mn |
| Dec 31, 2025 | 10.77 Mn |
| Sep 30, 2025 | 15.56 Mn |
| Jun 30, 2025 | 14.28 Mn |
| Mar 31, 2025 | 17.83 Mn |
| Dec 31, 2024 | 11.56 Mn |
| Sep 30, 2024 | 8.58 Mn |
| Jun 30, 2024 | 6.48 Mn |
| Mar 31, 2024 | 8.76 Mn |
| Dec 31, 2023 | 9.85 Mn |
| Sep 30, 2023 | 3.29 Mn |
| Jun 30, 2023 | 2.62 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Dec 31, 2022 | 12.98 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Jun 30, 2022 | 12.35 Mn |
| Mar 31, 2022 | 12.62 Mn |
| Dec 31, 2021 | 9.75 Mn |
| Sep 30, 2021 | 23.66 Mn |
API Access
Nektar Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();